Back
Syndax Pharmaceuticals Vs. United States Cellular Industry Stock Comparison
Sell
48
SNDX
Syndax Pharmaceuticals
Last Price:
20.25
Seasonality Move:
8.3%
Buy
71
USM
United States Cellular
Last Price:
44.44
Seasonality Move:
5.31%
Sell
48
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $20.29. The Score for SNDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- SNDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
United States Cellular (USM)
is a Buy
Is United States Cellular a Buy, Sell or Hold?
- The current United States Cellular [USM] share price is $45.10. The Score for USM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- USM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $20.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing selling pressure, which indicates risk of future bearish movement.
USM Stock Price Chart
What is United States Cellular's stock price today?
-
The United States Cellular share price today is $45.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and USM is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 39.21 | Sell |
Chaikin Money Flow: | -882942 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.71 - 22.09) | Sell |
Bollinger Bands (100): | (21.01 - 23.19) | Sell |
USM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.46 | Buy |
Relative Strength Index (14 RSI): | 67.73 | Buy |
Chaikin Money Flow: | 133355 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.95 - 42.71) | Buy |
Bollinger Bands (100): | (34.57 - 42.69) | Buy |
SNDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.49 | Sell |
20-day SMA: | 21.51 | Sell |
50-day SMA: | 22.17 | Sell |
200-day SMA: | 19.1 | Buy |
8-day EMA: | 21.31 | Sell |
20-day EMA: | 21.58 | Sell |
50-day EMA: | 21.81 | Sell |
200-day EMA: | 20.64 | Sell |
USM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.04 | Buy |
20-day SMA: | 39.26 | Buy |
50-day SMA: | 37.06 | Buy |
200-day SMA: | 40.1 | Buy |
8-day EMA: | 43.38 | Buy |
20-day EMA: | 40.49 | Buy |
50-day EMA: | 38.49 | Buy |
200-day EMA: | 36.73 | Buy |
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.65 per share, and an increase next year of $0.75 per share.
United States Cellular Earnings Growth & USM Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.75 per share, and a decrease next year of $3.46 per share.
Syndax Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
United States Cellular Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |